Laurent Fischer - 05 Apr 2023 Form 4 Insider Report for CTI BIOPHARMA CORP (CTIC)

Role
Director
Signature
/s/ Adam R. Craig, attorney-in-fact for Laurent Fischer
Issuer symbol
CTIC
Transactions as of
05 Apr 2023
Transactions value $
$0
Form type
4
Filing time
07 Apr 2023, 18:17:00 UTC
Previous filing
17 Mar 2023
Next filing
14 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTIC Stock Option (right to buy) Award $0 -80K -50% $0.00 80K 05 Apr 2023 Common Stock 80K $4.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option vests on the first to occur of (i) the date that is twelve months after the date of grant, and (ii) immediately prior to the first annual meeting of the Company's stockholders in 2024 at which one or more members of the Company's Board of Directors are to be elected, subject to the Reporting Person's continued service through such date or event.